Supplementation of l-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model

Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1

Lorenz C. Hofbauer, Francesca Gori, B. Lawrence Riggs et al. · Endocrinology · 1999 · 794 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension

Thomas Wallerath, Klaus K. Witte, Stephan Schäfer et al. · Proceedings of the National Academy of Sciences · 1999 · 288 citations

Medicine, Pharmacology, Physiology +13

Nitric oxide: A cytokine-induced regulator of bone resorption

Stuart H. Ralston, Ling‐Pei Ho, Miep Helfrich et al. · Journal of Bone and Mineral Research · 1995 · 245 citations

Medicine, Pathobiology, Bone Metabolism +10

Trabecular and endocortical bone surfaces in the rat: Modeling or remodeling?

Reinhold G. Erben · The Anatomical Record · 1996 · 215 citations · Full text

Medicine, Craniofacial Biology, Bone Metabolism +16

Nitric oxide donor alleviates ovariectomy-induced bone loss

Sunil J. Wimalawansa, G. De Marco, Pandu R. Gangula et al. · Bone · 1996 · 191 citations

Medicine, Orthopedic Surgery, Surgery +12